Bio-Rad Laboratories Other Non-Current Liabilities 2010-2024 | BIO

Bio-Rad Laboratories other non-current liabilities from 2010 to 2024. Other non-current liabilities can be defined as field containing the sum of all non-current liabilities that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • Bio-Rad Laboratories other non-current liabilities for the quarter ending September 30, 2024 were $0.198B, a 6.18% increase year-over-year.
  • Bio-Rad Laboratories other non-current liabilities for 2023 were $0.195B, a 0.41% decline from 2022.
  • Bio-Rad Laboratories other non-current liabilities for 2022 were $0.196B, a 7.53% increase from 2021.
  • Bio-Rad Laboratories other non-current liabilities for 2021 were $0.182B, a 7.5% decline from 2020.
Bio-Rad Laboratories Annual Other Non-Current Liabilities
(Millions of US $)
2023 $195
2022 $196
2021 $182
2020 $197
2019 $161
2018 $148
2017 $183
2016 $141
2015 $111
2014 $119
2013 $117
2012 $108
2011 $76
2010 $65
2009 $56
Bio-Rad Laboratories Quarterly Other Non-Current Liabilities
(Millions of US $)
2024-09-30 $198
2024-06-30 $194
2024-03-31 $192
2023-12-31 $195
2023-09-30 $186
2023-06-30 $202
2023-03-31 $199
2022-12-31 $196
2022-09-30 $205
2022-06-30 $177
2022-03-31 $180
2021-12-31 $182
2021-09-30 $214
2021-06-30 $219
2021-03-31 $229
2020-12-31 $197
2020-09-30 $182
2020-06-30 $175
2020-03-31 $173
2019-12-31 $161
2019-09-30 $143
2019-06-30 $145
2019-03-31 $144
2018-12-31 $148
2018-09-30 $172
2018-06-30 $179
2018-03-31 $191
2017-12-31 $183
2017-09-30 $148
2017-06-30 $148
2017-03-31 $404
2016-12-31 $141
2016-09-30 $141
2016-06-30 $416
2016-03-31 $374
2015-12-31 $111
2015-09-30 $111
2015-06-30 $115
2015-03-31 $275
2014-12-31 $119
2014-09-30 $270
2014-06-30 $302
2014-03-31 $292
2013-12-31 $117
2013-09-30 $258
2013-06-30 $248
2013-03-31 $246
2012-12-31 $108
2012-09-30 $202
2012-06-30 $167
2012-03-31 $172
2011-12-31 $76
2011-09-30 $129
2011-06-30 $144
2011-03-31 $136
2010-12-31 $65
2010-09-30 $110
2010-06-30 $101
2010-03-31 $109
2009-12-31 $56
2009-09-30 $55
2009-06-30 $52
2009-03-31 $57
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $9.168B $2.671B
Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $198.127B 25.27
Stryker (SYK) United States $138.991B 31.32
Boston Scientific (BSX) United States $131.097B 37.69
EssilorLuxottica (ESLOY) France $109.895B 0.00
Medtronic (MDT) Ireland $103.904B 15.43
Haleon (HLN) United Kingdom $43.864B 28.50
Lonza Group Ag (LZAGY) Switzerland $42.859B 0.00
GE HealthCare Technologies (GEHC) United States $36.052B 18.70
ResMed (RMD) United States $34.830B 28.62
Terumo (TRUMY) Japan $28.875B 0.00
Koninklijke Philips (PHG) Netherlands $23.602B 18.07
Zimmer Biomet Holdings (ZBH) United States $21.325B 13.58
Insulet (PODD) United States $18.698B 74.46
Baxter (BAX) United States $15.062B 9.80
Smith & Nephew SNATS (SNN) United Kingdom $10.781B 0.00
BellRing Brands (BRBR) United States $9.800B 39.43
Demant (WILYY) Denmark $7.926B 0.00
Lantheus Holdings (LNTH) United States $6.208B 14.42
Prestige Consumer Healthcare (PBH) United States $3.889B 19.34
ICU Medical (ICUI) United States $3.840B 36.56
Haemonetics (HAE) United States $3.789B 18.49
Perrigo (PRGO) Ireland $3.513B 10.34
Envista Holdings (NVST) United States $3.218B 23.97
QuidelOrtho (QDEL) United States $3.016B 19.41
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
GN Store Nord (GNNDY) Denmark $2.864B 18.36
Neogen (NEOG) United States $2.609B 30.10
LeMaitre Vascular (LMAT) United States $2.071B 50.34
Green Thumb Industries (GTBIF) United States $1.678B 29.37
AtriCure (ATRC) United States $1.498B 0.00
InMode (INMD) Israel $1.434B 8.63
AdaptHealth (AHCO) United States $1.383B 9.88
Maravai LifeSciences Holdings (MRVI) United States $1.356B 0.00
BioLife Solutions (BLFS) United States $1.271B 0.00
Curaleaf Holdings (CURLF) Canada $0.968B 0.00
Owens & Minor (OMI) United States $0.965B 7.54
CeriBell (CBLL) United States $0.964B 0.00
Phibro Animal Health (PAHC) United States $0.879B 15.49
Evolus (EOLS) United States $0.690B 0.00
Omeros (OMER) United States $0.597B 0.00
Capricor Therapeutics (CAPR) United States $0.594B 0.00
VAREX IMAGING (VREX) United States $0.584B 25.75
Surmodics (SRDX) United States $0.568B 0.00
Verano Holdings (VRNOF) United States $0.452B 0.00
Cresco Labs (CRLBF) United States $0.439B 0.00
Quanterix (QTRX) United States $0.403B 0.00
ZimVie (ZIMV) United States $0.375B 31.63
Biote (BTMD) United States $0.331B 7.26
Valneva SE (VALN) France $0.324B 0.00
Viemed Healthcare (VMD) United States $0.311B 29.56
Canopy Growth (CGC) Canada $0.308B 0.00
Sanara MedTech (SMTI) United States $0.294B 0.00
Cerus (CERS) United States $0.293B 0.00
OraSure Technologies (OSUR) United States $0.272B 18.20
Zynex (ZYXI) United States $0.263B 55.00
High Tide (HITI) Canada $0.242B 100.33
Aurora Cannabis (ACB) Canada $0.234B 0.00
Utah Medical Products (UTMD) United States $0.207B 14.29
Sanuwave Health (SNWV) United States $0.201B 2.82
MacroGenics (MGNX) United States $0.200B 0.00
Organigram Holdings (OGI) Canada $0.197B 0.00
TerrAscend (TSNDF) Canada $0.190B 0.00
Brainsway (BWAY) Israel $0.174B 92.40
FitLife Brands (FTLF) United States $0.145B 18.17
Jin Medical (ZJYL) China $0.133B 0.00
TriSalus Life Sciences (TLSI) United States $0.124B 0.00
Quipt Home Medical (QIPT) United States $0.107B 0.00
Fonar (FONR) United States $0.096B 10.81
Oramed Pharmaceuticals (ORMP) United States $0.096B 0.00
Veru (VERU) United States $0.095B 0.00
Exagen (XGN) United States $0.091B 0.00
InterCure (INCR) Israel $0.068B 0.00
Rockwell Medical (RMTI) United States $0.067B 34.67
Apyx Medical (APYX) United States $0.059B 0.00
Jushi Holdings (JUSHF) United States $0.056B 0.00
Ayr Wellness (AYRWF) United States $0.051B 0.00
Cytosorbents (CTSO) United States $0.050B 0.00
Modular Medical (MODD) United States $0.048B 0.00
Safety Shot (SHOT) United States $0.044B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
Allurion Technologies (ALUR) United States $0.023B 0.00
Nephros (NEPH) United States $0.016B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Innovative Eyewear (LUCY) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
Trinity Biotech (TRIB) Ireland $0.006B 0.00
Agape ATP (ATPC) $0.006B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.005B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Sharps Technology (STSS) United States $0.003B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 12.74
SNDL (SNDL) Canada $0.000B 0.00